Efficacy and Safety of BP02 (Trastuzumab Biosimilar) in HER2-Positive Metastatic Breast Cancer: A Multicenter Phase III Study
BP02（曲妥珠单抗生物仿制药）对 HER2 阳性转移性乳腺癌的疗效和安全性：一项多中心 III 期研究
期刊:Clinical Drug Investigation
影响因子:2.9
doi:10.1007/s40261-024-01374-y
M V T Krishna Mohan, Arpitkumar Prajapati, Rushabh Kothari, Srikrishna Mandal, Ranganatha Rao Srikanth, Rajnish Nagarkar, Shriram Khane, Ayyagari Santa, Disha Dadke
